InvestSMART

Nanosonics Limited (ASX: NAN) - ETF Exposure

Current share price for NAN : $2.950 0.04 (1.34%)+

Nanosonics (NAN) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in Manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories and research, development and commercialization of infection control and decontamination products and related technologies.

NAN General Information +

ASX Code NAN
Website N/A
Industry/Sector Health Care Supplies
Market Cap ($M) 882
NAN Share Price $2.950
Day High $3.000
Day Low $2.915
Last Close $2.990
NAN Share Price Movement $0.04 ( 1.34% )
Prices as at 16:40, 25 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to NAN

Nanosonics Limited (NAN) is held across 17 ETFs spanning strategies that include health care supplies exposure . Its weighting in those funds means performance can have an outsized influence - when NAN moves, funds like IMPQ, SMLL, SSO, ISO and FAIR that hold it can move with it.

For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 1% to NAN , while the average exposure across all 17 ETFs that hold it is around 0.2% .

Top ETF holdings

Last updated: ETF data and holdings as at 26 September 2026

Own NAN directly or through an ETF?

How does holding Nanosonics Limited (NAN) shares directly compare to ETFs that include it?

NAN Direct
IMPQ
ASX 		SMLL
ASX 		SSO
ASX 		ISO
ASX 		FAIR
ASX
Holdings 1 company 41 holdings 59 holdings 218 holdings 218 holdings 83 holdings
NAN Weight 100% 1% 1% 0.3% 0.3% 0.2%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.89% p.a. 0.39% p.a. 0.5% p.a. 0.55% p.a. 0.49% p.a.
Approx. Yield 0% 2.27% 2.93% 9.3% 4.36% 3.2%
Star Ratings - star starstarstarstarstar starstar starstarstar starstarstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not NAN's direct yield. Annual cost uses each ETF's MER.

NAN Exposure on $10,000 investment

How a $10,000 investment in Nanosonics Limited (NAN) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Nanosonics Limited (NAN) Direct share $2.950 1.03% +$103 $10,103
eInvest Better Future (Managed Fund) (IMPQ) Equity - Australia Small/Mid Cap $3.970 -2.22% -$222 $9,778
BetaShares Australian Small Companies Select Fund (Managed Fund) (SMLL) Equity - Australia Strategy $4.470 -1.54% -$154 $9,846
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) Equity - Australia Small/Mid Cap $14.420 -1.37% -$137 $9,863
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) Equity - Australia Small/Mid Cap $5.010 -1.18% -$118 $9,882
BetaShares Australian Sustainability Leaders ETF (FAIR) Equity - Australia Strategy $18.060 -1.63% -$163 $9,837

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Nanosonics Limited (NAN) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Nanosonics Limited (NAN) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Nanosonics Limited (NAN) price-sensitive announcements

NAN - 2026 Full Year Financial Results
Nanosonics Limited reported its financial results for the fiscal year ending 30 June 2026,
Nanosonics Limited (NAN)
25 Aug 2026 | 8:05 AM
NAN - Nanosonics to commence $20 million share buy-back program
Nanosonics Limited, a leader in infection prevention, announced on 5 November 2025 its int
Nanosonics Limited (NAN)
5 Nov 2025 | 9:34 AM
NAN - Appendix 4E
This document is the Appendix 4E for Nanosonics Limited, outlining its preliminary final r
Nanosonics Limited (NAN)
26 Aug 2025 | 8:27 AM
NAN - US FDA clearance received for next generation trophon
On 30 October 2020, Nanosonics Limited announced that it has received US FDA clearance for
Nanosonics Limited (NAN)
6 Aug 2025 | 9:29 AM

Nanosonics Limited (NAN) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Update - Notification of buy-back - NAN 25 Sep 2026 6:14PM $2.950 $2.950 fallen by 0%
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Update - Notification of buy-back - NAN 25 Sep 2026 8:10AM $2.990 $2.950 fallen by 1.34%
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Change of Director's Interest Notice 24 Sep 2026 2:22PM $2.970 $2.950 fallen by 0.67%
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Update - Notification of buy-back - NAN 24 Sep 2026 8:11AM $3.010 $2.950 fallen by 1.99%
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Notification of cessation of securities - NAN 23 Sep 2026 4:10PM $3.010 $2.950 fallen by 1.99%
Nanosonics Limited (NAN)
ORDINARY FULLY PAID
 Health Care $883 Application for quotation of securities - NAN 23 Sep 2026 9:57AM $3.090 $2.950 fallen by 4.53%

NAN Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2028F C2 $6.40 69.30% 46.50 0.00 0.00% 0.0%
2027F C2 $3.80 -35.00% 78.70 0.00 0.00% 0.0%
2026A $17.84 $5.80 -13.80% 66.90 0.00 0.00% 0.0%

NAN Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2026 A 2027 F 2028 F 2026 A 2027 F 2028 F 2026 A 2027 F 2028 F
Ansell Limited (ANN) $6,133M 0.1231 -0.0929 0.1003 20.3416 22.4246 20.3805 2.27% 1.88% 2.08%
Nanosonics Limited (NAN) $895M -0.1375 -0.3501 0.6933 51.8198 79.7333 47.0866 0.00% 0.00% 0.00%
Polynovo Limited (PNV) $674M -0.0899 -0.4186 1.0000 56.6860 97.5000 48.7500 0.00% 0.00% 0.00%

NAN Directors

Name Position Start Date
Mr Michael Kavanagh Chief Executive Officer, Managing Director 30 Jul 2012
Dr Larry Marshall Non-Executive Director 3 Oct 2023
Ms Marie Elizabeth McDonald Non-Executive Director 24 Oct 2016
Dr Tracey Leigh Batten Non-Executive Director 26 Sep 2023
Mr Gerard Dalbosco Non-Executive Director 14 Jan 2025
Ms Sarah Butler Non-Executive Director 19 Jan 2026
Mr Steven Andrew Sargent Non-Executive Director, Non-Executive Chairman 6 Jul 2016

Nanosonics Limited (NAN) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
10 Sep 2026 BUTLER, Sarah Buy Indirect Shares 18,500 $2.868 $53,063.600
3 Sep 2026 BATTEN, Tracey Buy Direct Shares 20,000 $2.653 $53,063.600
26 Aug 2026 DALBOSCO, Gerard Buy Indirect Shares 10,000 $2.873 $28,734.390

See all changes in directors' interest & trades for Nanosonics Limited (NAN) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

NAN Management

Name Position
Jason Burriss Chief Financial Officer
Sunny Pillai Chief Information Officer
Kimberly Hill Chief Marketing Officer, Regional President APAC
Jonathan Burdach Chief Medical Affairs and Scientific Officer
Rod Lopez Chief Operating Officer
Jodi Sampson Chief People & Culture Officer
Derek Minihane Chief Technology Officer
Matthew Carbines General Counsel,Company Secretary

NAN Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nanosonics Limited (NAN). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
24,374,937 (8.20%) Selector Funds Management Limited
20,791,758 (7%) Hyperion Asset Management Limited
17,816,067 (6%) Yarra Funds Management Limited

NAN Calendar of Events

Date Event
24 August 2027 Report (Annual)
24 August 2027 Report (Prelim)
23 February 2027 Report (Interim)
04 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.